In this work, we present the first report on the consequences of site-specific phosphorylation in human AGT, a metabolic enzyme whose deficit leads to PH1, a monogenic metabolic disease caused by mutations affecting protein stability and trafficking [19,24]. Here, AGT is linked to metabolic disease.